English | Español
Patient Daily | Jan 13, 2026

AbbVie announces $100B investment in US R&D and manufacturing
Patient Daily | Jan 13, 2026

AbbVie, Amgen and Lilly urge FDA reforms on drug manufacturing change rules
Patient Daily | Jan 13, 2026

UCSF Neurosurgery professor: 'Lots of evidence that 340B increases the cost of medications'
Patient Daily | Jan 13, 2026

Researchers discover new genetic links between fruit fly pigmentation and brain dopamine regulation
Patient Daily | Jan 13, 2026

J.P. Morgan Healthcare Conference marked by optimism but lacks major M&A announcements
Patient Daily | Jan 13, 2026

Patient advocacy groups urge Senate action on ACA enhanced tax credits
Patient Daily | Jan 12, 2026

Biopharma sector enters 2026 optimistic amid advances in rare disease policy
Patient Daily | Jan 12, 2026

Bristol Myers Squibb highlights early-stage research amid industry focus on late-stage deals

Trending
+ Regulatory
B. D. Benavides | Mar 18, 2026

Taxpayer advocate: Instead of improving product safety, litigation can result in the ‘opposite because runaway legal costs deter innovation'
+ Pharmaceuticals
Patient Daily | Mar 22, 2026

BioMarin pauses dosing and enrollment in two Voxzogo studies after safety signal
+ Regulatory
Patient Daily | Mar 20, 2026

Neurosurgeon DiGiorgio on 340B: '340B also takes money from taxpayers and makes everyone’s health insurance more expensive'
+ Pharmaceuticals
Patient Daily | Mar 22, 2026

FDA rejects REGENXBIO’s Hunter syndrome therapy as Denali awaits decision on rival drug